(Q39759213)

14 September 2017

Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations (English)

1 reference

14 September 2017

1 reference

Jaclyn L Myers

1

1 reference

PMC publication ID

3102564

14 September 2017

Scott E Hensley

series ordinal

2

1 reference

14 September 2017

1 April 2011

1 reference

Expert Review of Anti-infective Therapy

14 September 2017

1 reference

14 September 2017

9

1 reference

14 September 2017

4

1 reference

14 September 2017

385-388

1 reference

Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Permissive secondary mutations enable the evolution of influenza oseltamivir resistance

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Global transmission of oseltamivir-resistant influenza

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Developing new antiviral agents for influenza treatment: what does the future hold?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Mapping the antigenic and genetic evolution of influenza virus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102564

Adaptation to the fitness costs of antibiotic resistance in Escherichia coli

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21504394

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1586/ERI.11.2

1 reference

14 September 2017

1 reference

PMC publication ID

3102564

14 September 2017

PubMed publication ID

21504394

1 reference

PMC publication ID

3102564